While CRISPR-Cas9 remains the dominant and most widely utilized gene-editing platform, scientists have developed alternative technologies designed to address specific limitations, such as base editing and prime editing. These advanced techniques allow for more precise single-nucleotide corrections without causing double-stranded DNA breaks, potentially reducing off-target genetic mutation risks and expanding the scope of treatable hereditary diseases.